Cargando…
Salidroside Modulates Insulin Signaling in a Rat Model of Nonalcoholic Steatohepatitis
A growing body of evidence has shown the beneficial effects of salidroside in cardiovascular and metabolic diseases. This study aimed to evaluate the therapeutic effects of salidroside on nonalcoholic steatohepatitis (NASH) in rats and explore the underlying mechanisms related to insulin signaling....
Autores principales: | Li, Hongshan, Ying, Hao, Hu, Airong, Li, Dezhou, Hu, Yaoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309415/ https://www.ncbi.nlm.nih.gov/pubmed/28255329 http://dx.doi.org/10.1155/2017/9651371 |
Ejemplares similares
-
Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats
por: Yang, Ze-ran, et al.
Publicado: (2016) -
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018) -
Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
por: Hu, Ying-Bin, et al.
Publicado: (2018) -
Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015) -
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)